Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours

NCT03328065 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.

NCT NCT03328065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03328065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours
Lead sponsor
Centre Hospitalier Universitaire Dijon
Phase
Observational
Overall status
Terminated
Start date
December 19, 2017
Completion date
December 19, 2020
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-resecable metastatic cancer of the pancreas, non-resectable metastatic cancer of gastrointestinal neuroendocrine tumour, non-resectable metastatic cancer of the bile duct, non-resectable metastatic cancer of the colon, non-resectable metastatic cancer of the lung, non-resectable metastatic cancer of the rectosigmoid junction, non-resectable metastatic cancer of the rectum, non-resectable metastatic cancer of the stomach